369 related articles for article (PubMed ID: 16358941)
1. Somatostatin-receptor mediated diagnosis and treatment in gastrointestinal neuroendocrine tumours (GEP-NET's).
Oberg K
Rocz Akad Med Bialymst; 2005; 50():62-8. PubMed ID: 16358941
[No Abstract] [Full Text] [Related]
2. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
Hofsli E
Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
[TBL] [Abstract][Full Text] [Related]
3. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
[TBL] [Abstract][Full Text] [Related]
4. Role of somatostatin analogs in the management of non-functioning neuroendocrine tumors.
Pivonello R; Ferone D; Filippella M; Faggiano A; De Martino MC; Auriemma RS; Rota F; Lombardi G; Colao A
J Endocrinol Invest; 2003; 26(8 Suppl):82-8. PubMed ID: 15233220
[No Abstract] [Full Text] [Related]
5. Future aspects of somatostatin-receptor-mediated therapy.
Oberg K
Neuroendocrinology; 2004; 80 Suppl 1():57-61. PubMed ID: 15477719
[TBL] [Abstract][Full Text] [Related]
6. Radioguided surgery and systemic radionuclide therapy of neuroendocrine tumours.
Hodolic M; Fettich J; Marzola MC; Tonini E; Al-Nahhas A; Rubello D
In Vivo; 2010; 24(1):97-100. PubMed ID: 20133983
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin analogs for the treatment of neuroendocrine tumors.
Culler MD; Oberg K; Arnold R; Krenning EP; Sevilla I; Díaz JA
Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():9-17. PubMed ID: 21369878
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.
Janson ET; Oberg K
Cancer Chemother Biol Response Modif; 2003; 21():535-46. PubMed ID: 15338762
[No Abstract] [Full Text] [Related]
9. Clinical relevance of the expression of somatostatin receptors in digestive endocrine tumours.
Capurso G; Panzuto F; Delle Fave G
Dig Liver Dis; 2010 Mar; 42(3):173-4. PubMed ID: 20117969
[No Abstract] [Full Text] [Related]
10. Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges.
Castaño JP; Sundin A; Maecke HR; Villabona C; Vazquez-Albertino R; Navarro E; Oberg K
Cancer Metastasis Rev; 2014 Mar; 33(1):353-9. PubMed ID: 24390486
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of non-functioning neuro-endocrine gastro-enteropancreatic tumours.
Plöckinger U; Wiedenmann B
Neuroendocrinology; 2004; 80 Suppl 1():35-8. PubMed ID: 15477715
[TBL] [Abstract][Full Text] [Related]
12. [Somatostatin analogues for the treatment of gastro-entero-pancreatic neuroendocrine tumours].
Uomo G; Germano D; Rabitti PG
Minerva Endocrinol; 2001 Dec; 26(4):225-9. PubMed ID: 11782707
[TBL] [Abstract][Full Text] [Related]
13. Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study.
Qureshi SA; Burch N; Druce M; Hattersley JG; Khan S; Gopalakrishnan K; Darby C; Wong JL; Davies L; Fletcher S; Shatwell W; Sothi S; Randeva HS; Dimitriadis GK; Weickert MO
BMJ Open; 2016 May; 6(5):e010765. PubMed ID: 27147385
[TBL] [Abstract][Full Text] [Related]
14. [Neuroendocrine tumors--new diagnostics and treatment].
Oberg K
Ugeskr Laeger; 2010 Oct; 172(43):2941. PubMed ID: 21040670
[No Abstract] [Full Text] [Related]
15. Somatostatin analogues in functioning gastroenteropancreatic neuroendocrine tumours: literature review, clinical recommendations and schedules.
Massironi S; Conte D; Rossi RE
Scand J Gastroenterol; 2016; 51(5):513-23. PubMed ID: 26605828
[TBL] [Abstract][Full Text] [Related]
16. Pasireotide in the treatment of neuroendocrine tumors: a review of the literature.
Vitale G; Dicitore A; Sciammarella C; Di Molfetta S; Rubino M; Faggiano A; Colao A
Endocr Relat Cancer; 2018 Jun; 25(6):R351-R364. PubMed ID: 29643113
[TBL] [Abstract][Full Text] [Related]
17. [Somatostatin receptors and its analogs in diagnosis and treatment of human tumors].
Raĭkhlin NT; Smirnova EA; Delektroskaia VV
Vopr Onkol; 2010; 56(1):7-13. PubMed ID: 20361608
[No Abstract] [Full Text] [Related]
18. Advances in the treatment of gastroenteropancreatic neuroendocrine tumors.
Phan AT
Clin Adv Hematol Oncol; 2014 Dec; 12(12 Suppl 19):3-5. PubMed ID: 25768101
[No Abstract] [Full Text] [Related]
19. Medical treatment of neuroendocrine tumours.
Weber HC
Curr Opin Endocrinol Diabetes Obes; 2013 Feb; 20(1):27-31. PubMed ID: 23221494
[TBL] [Abstract][Full Text] [Related]
20. Treatment of neuroendocrine GEP tumours with somatostatin analogues: a review.
Arnold R; Simon B; Wied M
Digestion; 2000; 62 Suppl 1():84-91. PubMed ID: 10940693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
